Diary - News
All news ERYTECH Enters Into Strategic Supply Partnership
Second European source of donor red blood cells secured in preparation for expanded production of red blood cell-based therapeutics
Lyon (France) and Cambridge, MA (U.S.), February 20, 2020 – ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced that it has entered into a strategic partnership with the German Red Cross Blood Donor Service Baden-Württemberg-Hessen (GRCBDS) to complement the existing alliance with the French Blood bank (EFS) for the supply of donor red blood cells to manufacture its product candidates, including eryaspase, in Europe.
